Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor immunity

被引：16

作者：

Kato, Shingo ^{[1
]}

Berzofsky, Jay A. ^{[2
]}

Terabe, Masaki ^{[2
]}

机构：

[1] Yokohama City Univ, Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan

[2] NCI, Mol Immunogenet & Vaccine Res Sect, Vaccine Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA

来源：

FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷

关键词：

natural killer T cell; type II natural killer T cell; tumor immunology; immune regulation; immunosuppression; immunotherapy; lipid antigens; transforming growth factor beta; GROWTH-FACTOR-BETA; INVARIANT NKT CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; INFLAMMATORY-LIVER-DISEASE; GAUCHER-DISEASE; CD1D EXPRESSION; ADIPOSE-TISSUE; ALPHA-GALACTOSYLCERAMIDE; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS;

D O I：

10.3389/fimmu.2018.00314

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Natural killer T (NKT) cells are a unique T cell subset that exhibits characteristics from both the innate immune cells and T cells. There are at least two subsets of NKT cells, type I and type II. These two subsets of NKT cells have opposite functions in antitumor immunity. Type I NKT cells usually enhance and type II NKT cells suppress antitumor immunity. In addition, these two subsets of NKT cells cross-regulate each other. In this review, we mainly focus on immunosuppressive NKT cells, type II NKT cells. After summarizing their definition, experimental tools to study them, and subsets of them, we will discuss possible therapeutic applications of type II NKT cell pathway targeted therapies.

引用

页数：10

共 50 条

[21] Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment
Saadh, Mohamed J.
Rasulova, Irodakhon
Khalil, Mohamed
Farahim, Farha
Sarbu, Ioan
Ciongradi, Carmen Iulia
Omar, Thabit Moath
Alhili, Ahmed
Jawad, Mahmood Jasem
Hani, Thamer
Ali, Talat
Lakshmaiya, Natrayan
PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
[22] NATURAL-KILLER CELL-MEDIATED INHIBITION OF TUMOR-METASTASIS INVIVO
HANNA, N
SURVEY AND SYNTHESIS OF PATHOLOGY RESEARCH, 1983, 2 (1-2): : 68 - 81
[23] Natural killer cell-mediated lysis of freshly isolated human tumor cells
Carlsten, Mattias
Malmberg, Karl-Johan
Ljunggren, Hans-Gustaf
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 757 - 762
[24] Radiation therapy increases tumor vulnerability to natural killer cell-mediated control
Sia, J. I.
Chindris, I.
Hagekyriakou, J.
Johnstone, R.
Haynes, N.
RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S37 - S37
[25] CELL-MEDIATED IMMUNITY TO OCULAR MELANOMA - T-CELL INFILTRATION OF TUMOR
PULIAFITO, CA
AISENBERG, AC
WILKES, B
ALBERT, DM
YALE JOURNAL OF BIOLOGY AND MEDICINE, 1977, 50 (05): : 577 - 577
[26] Natural products promote susceptibility of tumor cells to natural killer cell-mediated immune surveillance
Kaiyuan, L.
Xingyu, R.
Huabin, W.
Hongqun, L.
Xiaoming, Z.
Huifang, Z.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1887 - 1887
[27] An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum
Smyth, MJ
Kelly, JM
Baxter, AG
Körner, H
Sedgwick, JD
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09): : 1611 - 1619
[28] Natural killer T cell-mediated antitumor immune responses and their clinical applications
Seino, Ken-ichiro
Motohashi, Shinichiro
Fujisawa, Takehiko
Nakayama, Toshinori
Taniguchi, Masaru
CANCER SCIENCE, 2006, 97 (09): : 807 - 812
[29] T cell– and B cell–independent adaptive immunity mediated by natural killer cells
Jacqueline G O'Leary
Mahmoud Goodarzi
Danielle L Drayton
Ulrich H von Andrian
Nature Immunology, 2006, 7 : 507 - 516
[30] A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Watkins-Schulz, Rebekah
Tiet, Pamela
Gallovic, Matthew D.
Junkins, Robert D.
Batty, Cole
Bachelder, Eric M.
Ainslie, Kristy M.
Ting, Jenny P. Y.
BIOMATERIALS, 2019, 205 : 94 - 105

← 1 2 3 4 5 →